Behavioral Management of Phosphorus in Hemodialysis Patients

Completed · Not applicable

Conditions studied: Cardiovascular Disease (CKD), Hyperphosphatemia

In brief

The purpose of this randomized clinical trial is to evaluate alternative technology-supported behavioral approaches to engaging 42 maintenance hemodialysis (HD) patients with persistent hyperphosphatemia in phosphorus binder adherence and dietary phosphorus restriction. Participants will be randomized to 1 of 3 intervention groups: (1) Education (Edu); (2) Edu + Self-Monitoring (SM); or (3) Edu + SM + Social Cognitive Theory (SCT)-based training program.

Key facts

Study ID

NCT02940743

Run by

NYU Langone Health

People needed

40

Starts

2018-04-23

Expected to finish

2018-05-01

Last updated by the study team

2018-05-31

Who can join

Age: 19 and older, up to 89. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Receiving thrice-weekly hemodialysis treatment for at least 3 months
• 3-month average serum phosphorus concentration >5.5 mg/dL

You may not qualify if…

• Unable to participate meaningfully in the combined Edu + SM + SCT intervention, including:
• Unable to read and/or speak English
• Self-monitoring application is currently available in English only (patients will not be excluded from participation on the basis of race/ethnicity)
• Cognitively-impaired
• Physically-impaired
• Institutionalized or otherwise having limited control over diet
• Life expectancy of <1 year per dialysis center staff
• Women who are pregnant or become pregnant during the study

Where it is running

• New York University School of Medicine — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.